metipranolol
|
美替洛爾
|
22664-55-7
|
AZD-7648
|
AZD-7648
|
2230820-11-6
|
(S)-5-hydroxy-3-(2-(((1-((1-methyl-1H-imidazol-4-yl)methyl)-1H-indol-6-yl)methylamino)methyl)-1H-indol-3-yl)isoindolin-1-one
|
(S)-5-hydroxy-3-(2-(((1-((1-methyl-1H-imidazol-4-yl)methyl)-1H-indol-6-yl)methylamino)methyl)-1H-indol-3-yl)isoindolin-1-one
|
2375482-51-0
|
1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE
|
1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE
|
869497-75-6
|
MK-0941
|
MK-0941
|
1137916-97-2
|
Batefenterol
|
BATEFENTEROL
|
743461-65-6
|
Mirogabalin besylate
|
10928苯磺酸鹽
|
1138245-21-2
|
Doripenem
|
多尼培南
|
148016-81-3
|
N-{(1S,2R)-1-benzyl-3-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-hydroxy-3-oxopropyl}-5-chloro-1H-indole-2-carboxaMide|ingliforib
|
CPD2802
|
186392-65-4
|
CPD1815
|
CPD1815
|
2166387-64-8
|
BLU-285
|
阿伐普替尼
|
1703793-34-3
|
3-(3-(((4-((Dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide
|
BI-847325
|
1207293-36-4
|
Bardoxolone
|
2-氰基-3,12-二氧代齊墩果-1,9-二烯-28-酸
|
218600-44-3
|
AZD5069
|
AZD5069
|
878385-84-3
|
IPI-549
|
IPI-549
|
1693758-51-8
|
CPDD0945
|
CPDD0945
|
1632118-69-4
|
5H-Imidazo[5,1-a]isoindole-5-ethanol, α-cyclohexyl-
|
1-環(huán)己基-2-(5H-咪唑并[5,1-A]異吲哚-5-基)乙醇
|
1402836-58-1
|
N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline
|
EW-7197
|
1352608-82-2
|
7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine
|
CPI-444
|
1202402-40-1
|
1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate
|
莫博替尼
|
1847461-43-1
|
EED226
|
EED226
|
2083627-02-3
|
NVP-BGJ398
|
FGFR抑制劑(NVP-BGJ398)
|
872511-34-7
|
Derazantinib
|
德拉贊替尼
|
1234356-69-4
|
Olodaterol
|
奧達(dá)特羅
|
868049-49-4
|
Tropifexor
|
Tropifexor
|
1383816-29-2
|
H3B-6527
|
H3B-6527
|
1702259-66-2
|
GLPG0187
|
GLPG0187, 一種廣譜的INTEGRIN受體拮抗劑,具有抗腫瘤活性
|
1320346-97-1
|
1-((S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea
|
PZM-21
|
1997387-43-5
|
2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
|
瑞格非尼
|
755037-03-7
|
R788(Fostamatinib disodium)
|
R788(FOSTAMATINIB DISODIUM)
|
1025687-58-4
|
GSK2256098
|
GSK-2256098
|
1224887-10-8
|
A-966492
|
A-966492
|
934162-61-5
|
AZD8931
|
AZD8931
|
848942-61-0
|
Acetic acid, 2-[[4-[(1S)-1-[[(4,5-dichloro-1,6-dimethyl-1H-indol-2-yl)carbonyl]amino]-2-hydroxyethyl]phenyl]sulfonyl]-
|
Acetic acid, 2-[[4-[(1S)-1-[[(4,5-dichloro-1,6-dimethyl-1H-indol-2-yl)carbonyl]amino]-2-hydroxyethyl]phenyl]sulfonyl]-
|
2244452-09-1
|
PI3K-IN-2
|
PI3K/MTOR抑制劑
|
1225037-39-7
|
Nrf1-activator-1
|
NRF1-ACTIVATOR-1
|
1474034-05-3
|
4-Piperidinecarboxylic acid, 1-(2,3-dichlorobenzoyl)-4-[[5-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridinyl]methyl]-
|
化合物 T34787
|
1453099-83-6
|
Thieno[2,3-d]pyrimidine-3(2H)-acetic acid, 6-bromo-1,4-dihydro-α,α,5-trimethyl-2,4-dioxo-, 1,1-dimethylethyl ester
|
Thieno[2,3-d]pyrimidine-3(2H)-acetic acid, 6-bromo-1,4-dihydro-偽,偽,5-trimethyl-2,4-dioxo-, 1,1-dimethylethyl ester
|
1434643-33-0
|
RTA dh404
|
RTA dh404
|
1191265-33-4
|
3-Pyrrolidinecarboxylic acid, 1-[[7-cyano-2-[3'-[[3-[[(3R)-3-hydroxy-1-pyrrolidinyl]methyl]-1,7-naphthyridin-8-yl]amino]-2,2'-dimethyl[1,1'-biphenyl]-3-yl]-5-benzoxazolyl]methyl]-, (3R)-
|
INCB084550
|
2230911-59-6
|
BDTX-189
|
BDTX-189
|
2414572-47-5
|
Lazertinib
|
YH-25448
|
1903008-80-9
|
Parsaclisib
|
化合物PARSACLISIB
|
1426698-88-5
|
ITF2357
|
N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽水合物
|
732302-99-7
|
7-(BENZOYLAMINO)-4,9-DIHYDRO-4-METHYL-9-OXO-PYRAZOLO[5,1-B]QUIZOLINE-2-CARBOXYLIC ACID
|
7-(BENZOYLAMINO)-4,9-DIHYDRO-4-METHYL-9-OXO-PYRAZOLO[5,1-B]QUINAZOLINE-2-CARBOXYLIC ACID
|
77422-99-2
|
1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)-
|
化合物 T10476
|
2471967-92-5
|
ART558
|
化合物ART558
|
2603528-97-6
|
IPN-60090
|
IPN-60090
|
1853164-83-6
|
4-Cyano-N-(1,2-dihydro-1,3-dimethyl-2-oxo-6-quinolinyl)benzenesulfonamide
|
NI-42
|
1884640-99-6
|
CPD1640
|
BMS-986195
|
1912445-55-6
|
Galloflavin
|
培黃素
|
568-80-9
|
DGAT-1 inhibitor
|
DGAT-1 抑制劑
|
959122-11-3
|
Tetrazolo[1,5-a]pyrimidine-6-carboxamide, 4,7-dihydro-4,5,7,7-tetramethyl-N-(3-phenyl-1H-indazol-5-yl)-
|
化合物EB-42486
|
2390475-81-5
|
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]-
|
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]-
|
1370363-74-8
|
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide
|
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide
|
1030203-81-6
|
Imidazole ketone erastin (PUN30119)
|
沒找到
|
1801530-11-9
|
BI 2536
|
BI 2536
|
755038-02-9
|
(2S)-1-(3-Azabicyclo[3.1.0]hex-3-ylcarbonyl)-N-(2-cyclopropylethyl)-2,3,4,5-tetrahydro-2-methyl-4-oxo-1H-1,5-benzodiazepine-7-carboxamide
|
BAY-6035
|
2247890-13-5
|
CP 94253 hydrochloride
|
CP 94253鹽酸鹽
|
845861-39-4
|
DS-7423
|
DS 7423)
|
1222104-37-1
|
1H-Pyrrole-2-carboxamide, 1-(4-pyridinylmethyl)-N-[4-[(2R)-1-(2-pyridinyl)-2-pyrrolidinyl]-2-thiazolyl]-
|
化合物SEC61-IN-1
|
2484865-42-9
|
4-Thiazoleacetamide, 2-[(6-methyl-2-pyridinyl)amino]-N-(5-methyl-2-thiazolyl)-
|
HQ461
|
1226443-41-9
|
Unii-2W150K0uuc
|
Odevixibat
|
501692-44-0
|
Benzamide, N-[5-(3,5-dicyano-1,4-dihydro-1,2,6-trimethyl-4-pyridinyl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethyl-
|
BAY-3827
|
2377576-35-5
|
KW-2478
|
KW-2478
|
819812-04-9
|
2-((S)-1-acryloyl-4-(7-(8-methylnaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile
|
MRTX-1257
|
2206736-04-9
|
Pemigatinib
|
培米加替尼
|
1513857-77-6
|
Pirtobrutinib
|
LOXO-305
|
2101700-15-4
|
SC-43
|
SC-43
|
1400989-25-4
|
VR23
|
VR23
|
1624602-30-7
|
SGI 7079
|
3-[2-[[3-氟-4-(4-甲基-1-哌嗪基)苯基]氨基]-5-甲基-7H-吡咯并[2,3-D]嘧啶-4-基]苯乙腈
|
1239875-86-5
|
FIIN-3
|
FIIN-3
|
1637735-84-2
|
EBI-2511
|
化合物EBI-2511
|
2098546-05-3
|
4-Piperidinone, 3,5-bis[(4-methylphenyl)methylene]-, hydrochloride (1:1)
|
NSC632839hydrochloride
|
157654-67-6
|
NSC 348884
|
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺
|
81624-55-7
|
Everolimus
|
依維莫司
|
159351-69-6
|
Wnt-C59
|
PORCN酶活性和WNT抑制劑(WNT-C59)
|
1243243-89-1
|
Romidepsin
|
羅米地辛
|
128517-07-7
|
Ceralasertib
|
AZD6738
|
1352226-88-0
|
DAPT (GSI-IX, LY-374973)
|
DAPT
|
208255-80-5
|
GSK126
|
GSK126
|
1346574-57-9
|
Trichostatin A
|
曲古柳菌素A
|
58880-19-6
|
Q-VD-OPh
|
(3S)-5-(2,6-二氟苯氧基)-3-[[(2S)-3-甲基-1-氧代-2-[(2-喹啉甲?;?氨基]丁基]氨基]-4-氧代-戊酸
|
1135695-98-5
|
(-)-Blebbistatin
|
(-)-BLEBBISTATIN
|
856925-71-8
|
Bucladesine sodium
|
二丁酰環(huán)磷腺甙
|
16980-89-5
|
Pevonedistat
|
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氫-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羥基環(huán)戊基]甲基酯
|
905579-51-3
|
(R)-GNE-140
|
(R)-GNE-140
|
2003234-63-5
|
Ulixertinib
|
4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羥基乙基]-1H-吡咯-2-甲酰胺
|
869886-67-9
|
LGK974
|
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-聯(lián)吡啶]-5-乙酰胺
|
1243244-14-5
|
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-
|
3-去氮腺嘌呤A
|
120964-45-6
|
Bleomycin sulfate
|
硫酸博萊霉素
|
9041-93-4
|
Bafilomycin A1
|
巴佛洛霉素 A1
|
88899-55-2
|
Laduviglusib monohydrochloride
|
CHIR-99021鹽酸鹽
|
1797989-42-4
|
Z-VAD(OMe)-FMK
|
氟甲基酮
|
187389-52-2
|
Adenosine,3'-[[(2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyl-, dihydrochloride
|
嘌呤霉素二鹽酸鹽水合物
|
58-58-2
|
Poly(ethylene glycol)
|
聚乙二醇
|
25322-68-3
|
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine
|
吉非替尼
|
184475-35-2
|
STM2457
|
STM2457
|
2499663-01-1
|
6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one hydrochloride
|
帕布昔利布鹽酸鹽
|
827022-32-2
|
(5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
|
依托泊苷
|
33419-42-0
|